Clinical Trial Update: Mesalazine Treatment in IBS (The MIBS Study) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating mesalazine for Irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Mesalazine (mesalazine)

Snippet

Sponsor: Hans Törnblom | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED